The forkhead box C2 (Foxc2) protein is a member of the forkhead/winged helix transcription factor family and plays an essential role in cardiovascular development. Previous studies showed that Foxc2 null mouse embryos die during midgestation or just after birth with severe cardiovascular defects, including interruption, coarctation of the aortic arch and ventricular septal defects. These are also seen in human congenital heart disease. However, the tissue specific role of Foxc2 in aortic arch remodelling is not yet fully understood. Here we show that Foxc2 is expressed in a restricted pattern in several cell populations, including the mesenchyme and endothelium of pharyngeal arch arteries, which are important for cardiovascular development. In this study, we use a conditional knockout approach to examine the tissue specific role of Foxc2 in aortic arch remodelling. We demonstrate that mouse embryos lacking Foxc2 in Nkx2.5-expressing mesenchyme and endothelium of pharyngeal arch arteries display aortic arch interruption type B and ventricular septal defects. In contrast, conditional deletion of Foxc2 in Tie2-expressing endothelial cells does not result in aortic arch or ventricular septal defects, but does result in embryonic lethality due to peripheral oedema. Our data therefore provide for a detailed understanding of the role of mesenchymal Foxc2 in aortic arch remodelling and in the development of ventricular septum.
Human congenital heart defects are the most common birth defect, affecting 9 in 1000 live births (28) . Outflow tract defects, aortic arch malformation and ventricular septal defects (VSD) are common forms of human congenital heart disease (14) . In vertebrates, the heart is the first organ that develops through a complicated series of morphogenetic events involving the interaction between cells of different embryonic sources (3, 23) . The mature aortic arch and great vessels derive from the embryonic pharyngeal arch arteries and the aortic sac. Five pairs of pharyngeal arch arteries appear in a rostrocaudal direction during embryogenesis and form the precursors of the great vessels and large arteries in the head and neck. Arch arteries develop from the aortic sac and end in the dorsal aorta and finally contribute to specific arteries (25) . At embryonic day 9.5 (E9.5) in mice, the first and second arch arteries appear. At E10.5, the first and second arch arteries disappear, while the third, fourth and sixth arch arteries appear. All arch arteries undergo a remodelling process to malities. Furthermore, Foxc2 ablation in the mesenchyme by Nkx2.5-Cre mice causes an interrupted aortic arch and other cardiovascular defects.
MATERIALS AND METHODS

Generation of Foxc2 conditional knockout mice.
A genomic DNA fragment containing the coding exon of the mouse Foxc2 gene (18) was isolated from a 129/SvJ mouse genomic library (Stratagene, CA, USA). A loxP DNA fragment was inserted into the 5' untranslated region (UTR) of this Foxc2 gene. Another loxP DNA and FRT-flanked neomycin resistant gene (Neo R ) under control of the PGK promoter was inserted into the 3' UTR to enable positive selection (31) . Diphtheria toxin A (DTA) gene and thymidine kinase (TK) gene under control of the polyoma enhancer/herpes simplex virus thymidine kinase (MC1) promoter were inserted flanking the 5' and 3' UTRs respectively (Fig. 1A) . DTA was used as a negatively selective marker that allows for selection against unwanted random integrants. The Neo R cassette was used for positive selection of cells containing an integrated copy of the targeting vector using G418 (Sigma Aldrich, Co., USA), whereas TK was used as a negatively selective marker for randomly integrated cells using gancyclovir (17, 32) . The targeting vector was electroporated into embryonic stem cells (ES) and G418 and gancyclovir resistant ES colonies were picked and subjected to Southern blot analysis using Hind III & SacI cut labeled probe (Fig. 1B, black bar) . Two clones were obtained and were used to generate chimeric mice as described previously (27) . Chimeric mice were crossed with female C57BL/6J mice to obtain Foxc2 floxed (fl)-neo mice. These mice were then crossed with Act-FLPe mice (24) to remove the FRT-flanked PGK-Neo R cassette, thus generating Foxc2 fl/+ mice (Fig. 1A) . The genotype of adult mice or embryos was determined by polymerase chain reaction (PCR) analysis using 3 primers, A: 5'-ACTCGCACCGGC TAGGACTG-3', B: 5'-GCATCTGGGTAGGGG AACG-3', and C: 5'-ATCACTTGAACTCCGCGC CCTG-3'. The wild-type and Foxc2 fl alleles generate amplicons of 360 bp and 600 bp respectively (Fig. 1C) . Foxc2 fl/+ heterozygote mice were intercrossed to make homozygote. Homozygote Foxc2 fl/fl mice were fertile and did not show any phenotypical and histological abnormalities.
Mouse strain maintenance. Nkx2.5-Cre knock-in mice, Tie2-Cre transgenic mice and R26R reporter mice were described previously (11, 21, 26) . All correctly establish an embryonic and postnatal circulatory system. Asymmetrically programmed regression and persistence of specific arch arteries are involved in the remodelling process. Until E15.5, the aortic arch is formed by remodelling of the aortic sac, the left fourth arch artery and left dorsal aorta. The right fourth arch artery contributes to the brachiocephalic artery and proximal part of the right subclavian artery. The left sixth arch artery remodels into the pulmonary trunk and ductusarteriosus Botalli, while the right sixth artery regresses and ultimately disappears. The right and left third arch artery reform into the bilateral common carotid arteries (6) (7) (8) 25) . Forkhead box C2 (Foxc2)/mesenchymal forkhead-1 is a member of the forkhead family of transcription factors. Foxc2 is strongly expressed in the developing heart, limb, lymphatic and blood vessels, cartilaginous tissues, head mesenchyme, kidney, bones and dorsal aortas, suggesting that it is involved in a wide variety of developmental processes (19) . Foxc2 plays an essential role in the vascular/lymphatic vessel formation in cardiovascular development and diseases. Mutations in FOXC2 in humans cause lymphedema-diatichiasis syndrome (LD syndrome), a rare autosomal dominant genetic multisystem disorder characterised by swelling of the legs because of fluid accumulation, and the development of extra eyelashes (distichiasis). Congenital heart disease occurs in 7% of individuals with LD syndrome. Additional anomalies sometimes associated with this disorder include ventricular and atrial septal defects, patent ductusarteriosus, cleft palate, and abnormal heart rhythm (16). Foxc2 is important for the remodelling of pharyngeal arch arteries to the aortic arch. Our laboratory and others have shown that null mutation of Foxc2 causes perinatal lethality, a defective lymphatic system, skeletal malformation and aortic arch patterning defects (6) . The most common aortic arch patterning defect is an interrupted aortic arch type B (IAA-B), in which part of aortic arch between the left common carotid artery and left subclavian artery is interrupted (6, 30) . It has been previously shown that Foxc2 mRNA is expressed in the pharyngeal arch artery mesenchyme and endothelial cells (6) . To investigate the tissue-specific requirement of Foxc2 signalling in remodelling of the aortic arch, we generated Foxc2 conditional knockout mice. We generated mice with Foxc2 specifically knocked out either in the mesenchyme and the endothelium, or only in the endothelium. We found that all Foxc2 conditional mutant embryos die just after birth due to cardiac abnor-Intracardiac ink injection. For examination of aortic arch remodelling, embryos between E12.5 and E13.5 were selected. Indian ink (Winsor & Newton Ink, England) was injected into the left ventricle of the heart using custom-made glass pipettes. After injection embryos were fixed overnight in 4% paraformaldehyde (PFA; Sigma-Aldrich, Co., USA) at 4°C, dehydrated through a series of methanol/phosphate buffer saline (PBS) to 100% methanol and cleared in 2 : 1 ratio of benzyl benzoate and benzyl alcohol (Nacalai Tesque, Inc., Japan). Images were acquired with a Leica MZ6 microscope using an Olympus DP12 digital microscope camera.
X-gal staining. For whole-mount X-gal staining, dissected embryos were isolated in ice-cold PBS and fixed with 0.2% glutaraldehyde (Wako Pure Chemimice were maintained by continual crossing with C57BL/6J mice. Foxc2 fl/fl mice were maintained as homozygotes in their own strain background. Mesenchymal and endothelial cell-specific Foxc2 conditional knockout (cKO) mice were obtained as follows. In the first cross, Nkx2. a confocal laser scanning microscope (FluoView FV1000, Olympus).
RESULTS
Generation of conditional Foxc2
fl/fl mice To investigate the tissue specific role of Foxc2 during embryonic development, a targeting vector containing Foxc2 conditional allele was electroporated into the mouse ES cells and the ES colonies were selected with G418 and gancyclovior (Fig. 1A) fl/+ mice. These mice were intercrossed to produce homozygotes and this was confirmed by PCR (Fig. 1C ).
Nkx2.5-Cre and Tie2-Cre expression in the pharyngeal arches
Previous studies showed that Nkx2.5-Cre expression was first detected as early as E7.5 in the cardiac crescent and pharyngeal endoderm and Tie2-Cre expression was detected in all endothelial cells at E9.5 (11, 21) . To investigate Nkx2.5-and Tie2-directed expression of Cre recombinase, we crossed our Cre mice with the R26R reporter mice, which express β-galactosidase (β-gal) only in the presence of Cre recombinase. Nkx2.5-Cre; R26R and Tie2-Cre; R26R embryos at E10.5 were stained for X-gal to reveal Cre mediated β-gal activity. Usually, the heart field is patterned into primary heart field and secondary heart field on the basis of molecular, genetic and morphological events. The primary heart field contributes mostly to the left ventricle and the left and right atrium, whereas the secondary heart field develops mainly into the right ventricle, outflow tract and both atria (1, 34) . In Nkx2.5-Cre; R26R embryos, strong β-gal activity was detected in the pharyngeal arch core mesoderm and secondary heart field ( Fig. 2A) . Frontal sections of Nkx2.5-Cre; R26R cal Industries, Ltd.) at 4°C for 10 min, washed in PBS and stained for X-gal (5-bromo-4-chlro-3-indoyl β-D-galactopyranoside, Takara Biochemicals, Japan) solution at 37°C overnight. For X-gal staining on sections, dissected embryos were fixed in 4% PFA/ PBS on ice for 30 min and then processed through graded sucrose/PBS solutions (5%, 10%, 15% and 20%) until the embryos sank. The embryos were embedded in Tissue-Tek O.C.T. compound (Sakura Finetek Japan) and stored at −85°C. Sections, 10 μm in thickness, were obtained using a cryostat and rinsed with buffer containing 2 mM magnesium chloride, 0.02% NP-40, and 0.01% sodium deoxycholate. The sections were then stained in the same buffer with 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 1 mg/mL X-gal at 37°C. The stained slides were then washed, postfixed in 4% PFA/PBS, dehydrated in an ethanol/xylene series and mounted in Mount-Quick mounting medium (Daido Sangyo Co., Japan). Whole mount and section X-gal staining was carried out on five heterozygous mice. Images were captured with an Olympus DP72 digital camera through an Olympus BX-51 microscope.
Histology. Dissected embryos were fixed in 4% PFA/PBS, dehydrated in an ethanol/xylene series and embedded in paraffin wax by standard procedures. Sections of 10 μm thickness were dewaxed, rehydrated in a xylene/ethanol series, and stained with haematoxylin/eosin solution (H&E) by standard procedures. Sectional images were acquired using an Olympus BX-51 light microscope and an Olympus DP72 digital camera. H&E staining was carried out on a minimum of five control and five mutant embryos.
Immunofluorescence microscopy. Immunofluorescence staining was performed as previously described (2) . Dissected embryos were fixed in 1% formalin/PBS (Wako Pure Chemical Industries, Ltd.) overnight at 4°C. Embryos were processed in graded sucrose and embedded in O.C.T. compound. Frozen sections (10 μm) were incubated in a blocking buffer (3% bovine serum albumin, 0.1% Tween-20 in PBS) for 1 h. Sections were incubated with rat monoclonal anti-mouse Foxc2 antibody (4) diluted 1 : 1,000 in blocking solution overnight at 4°C. Sections were washed and then incubated with Alexafluor 488 donkey anti-rat IgG (1 : 200, Life technologies) for 1 h at room temperature. All slides were stained with the nuclear marker DAPI (DOJINDO Molecular Technologies, Inc). Images were taken using compound heterozygote mice showed that Nkx2.5-driven Cre activity is strongly expressed in the mesenchyme surrounding the third, fourth and sixth pharyngeal arch arteries. β-gal activity was also detected in endothelium, endoderm and ectoderm of pharyngeal arches (Fig. 2B, C) . These results are consistent with previously published data (21) . Tie2-Cre transgene is driven by an endothelium-specific receptor, tyrosine kinase promoter/enhancer. Tie2 expression persists in the endothelial cells throughout embryogenesis. Whole-mount X-gal staining in Tie2-Cre; R26R mice showed that β-gal is uniformly detectable in the endothelial cells lining the lumen of all blood vessels (Fig. 2D) . Frontal sections of E10.5 embryos showed that β-gal is strongly expressed in the endothelium of the pharyngeal arches whereas mesenchymal cells were completely negative for β-gal staining (Fig. 2E, F) . Tie2-Cre expression was also consistent with the previous study (11) . These results revealed that Nkx2.5-Cre was expressed in both endothelium and mesenchyme of pharyngeal arch arteries whereas Tie2-Cre was expressed only in the endothelium, as expected.
Mesenchymal and endothelial specific Foxc2 deletion
To investigate the cell type-specific expression of Foxc2, immunostaining in the developing pharyngeal arch arteries was carried out. In E10.5 control (Foxc2 fl/fl ) embryos, Foxc2 protein was strongly expressed in the endothelial cells and surrounding mesenchymal cells of third, fourth and sixth pharyngeal arch arteries (Fig. 3A-C) . This protein expression data is consistent with our previous observation of Foxc2 mRNA expression in the arch arteries (6) . These data suggest that Foxc2 is expressed in the same regions as Nkx2.5 and Tie2, i.e. that of mesenchyme and endothelium of pharyngeal arches (Fig. 2) . To determine whether Foxc2 expression in Nkx2.5-expressing mesenchymal and endothelial cells is required for correct development of the pharyngeal arches, we performed conditional deletion of Foxc2 by crossing our Foxc2 fl/fl mice with Nkx2.5-Cre and Tie2-Cre mice. Immunostaining with anti-Foxc2 antibody and confocal microscopy of Nkx2.5-Cre; Foxc2 fl/fl embryonic sections at E10.5 revealed that Foxc2 was efficiently deleted in the mesenchymal cells surrounding the endothelium of the pharyngeal arches compared to control embryos (Fig. 3D-F) . To determine whether expression of Foxc2 in the endo- 
Mesenchymal Foxc2 inactivation causes interrupted aortic arch
Previous studies have shown that Foxc2 null mice died prenatally or perinatally with cardiovascular defects, suggesting that the severity of the defect may be caused by different cell type-specific Foxc2 functions (6, 30) . In most cases, abnormalities are associated with aortic arch interruption, coarctation or hypoplasia of the fourth arch arteries and VSD (6, 30) . E18.5 control (Foxc2 and Tie2-Cre; Foxc2 fl/fl mutant embryos were examined for cardiac abnormalities. Upon careful gross anatomical examination, we found that in control embryos, the left common carotid, left subclavian and right brachiocephalic arteries branch directly from the ascending aorta. This indicates normal aorthelium of the pharyngeal arches is required for aortic arch remodelling, Foxc2 was conditionally deleted in the endothelium by crossing our Foxc2 fl/fl mice with Tie2-Cre mice. Immunostaining and confocal microscopy of E10.5 Tie2-Cre; Foxc2 fl/fl embryonic sections revealed that Foxc2 was efficiently deleted specifically in the endothelial cells, whereas the mesenchymal expression of the pharyngeal arch arteries was unaffected (Fig. 3G-I ). These data clearly indicate that Nkx2.5-Cre efficiently inactivated Foxc2 both in the mesenchyme and in the endothelium of the pharyngeal arch arteries whereas Tie2-Cre deleted Foxc2 only in the endothelium of the pharyngeal arches. tion of pericardial effusion (Fig. 5F ). In these mice, embryonic lethality was likely to be secondary to the heart failure.
Mesenchymal Foxc2 is required for aortic arch remodelling in the critical stage
Our data clearly indicate that Foxc2 conditional mutant embryos showed cardiovascular phenotypes such as interrupted aortic arch and VSD. To explore the critical stage of Foxc2 function in aortic arch remodelling, we performed India ink injection at E12.5 and E13.5 in control and mutant embryos. At E12.5, aortic arch remodelling was comparable between control ( Fig. 6A) and Nkx2.5-Cre; Foxc2 fl/fl conditional mutant embryos (Fig. 6B) . Aortic arch remodelling defect was clearly apparent at E13.5 in Nkx2. Foxc2 fl/fl embryos (Fig. 6D ) as compared to control embryos (Fig. 6C) . In Tie2-Cre; Foxc2 fl/fl embryos, aortic arch patterning was normal, i.e. similar to controls (data not shown). These results indicate that Foxc2 inactivation in the mesenchyme does not affect the initial formation and patterning of pharyngeal arch arteries, but causes their defective remodelling at a later stage.
DISCUSSION
In this study, we present convincing evidence demonstrating that inactivation of Foxc2 from the Nkx2.5-expressing cells leads to cardiovascular defects including interrupted aortic arch type B and VSD. Pharyngeal arch arteries are initially formed as bilateral symmetric vessels. During aortic arch remodelling, some of the arch artery segments degenerate while other segments remain and contribute to definitive left sided aortic arch and major vessels in the adult. This remodelling is a complex process governed by a signalling network that remains poorly tic arch formation in control embryos (Fig. 4A) . We observed that all of Nkx2.5-Cre; Foxc2 fl/fl conditional mutant embryos (n = 7) showed an aortic arch remodelling defect (Table 1) . This defect included an interrupted aortic arch type B (IAA-B), where part of the aortic arch between the left common carotid artery and the left subclavian artery was missing (Fig. 4B) . We did not find any Tie2-Cre; Foxc2 fl/fl embryos with aortic arch interruption (Fig. 4C) , suggesting that Foxc2 in the mesenchyme plays an important role in aortic arch remodelling.
Nkx2.5-Cre-and Tie2-Cre-specific deletion of Foxc2 results in other cardiovascular defects
Next we examined whether any other cardiovascular defect is present in the conditional mutant embryos. A summary of the cardiovascular and other defects is shown in Table 1 . Histological examination of E18.5 control heart showed that ventricles are well separated (Fig. 5A) . Transverse sections of E18.5 Nkx2. Foxc2 fl/fl embryos showed VSD where membranous portions of the ventricular septum failed to fuse (Fig. 5B) . In contrast, we did not find any VSD in the Tie2-Cre endothelial-specific conditional Foxc2 mutant embryos, which were very similar to control embryos (Fig. 5C) . These results were consistent with our observation where we did not find any aortic arch interruption in the Tie2-Cre; Foxc2 fl/fll conditional mutant embryos at E18.5. These data suggest that aortic arch interruption has some correlation with VSD. With microscopic examination of E14.5 control and mutant embryos, we did not find any gross structural abnormalities in the control (Fig. 5D) and Nkx2. Foxc2 fl/fl conditional mutant embryos (Fig. 5E ). These embryos displayed spontaneous movements and cardiac pulsations. On the other hand, Tie2-Cre; Foxc2 fl/fll embryos showed peripheral oedema that may be due to the accumula- mice. X-gal staining confirmed Nkx2.5 expression in mesenchyme and endothelium and Tie2 expression in endothelial cells of the pharyngeal arch arteries (Fig. 2) . Mesenchyme specific deletion of Foxc2 in Nkx2. Foxc2 fl/fl mice showed interrupted aortic arch type B. This phenotype is also common in DiGeorge syndrome in humans which is characterized by microdeletion of chromosome 22q11.2 (29) . This result provides the first evidence of a tissuespecific role of Foxc2 in aortic arch remodelling. Type B interruption of the aortic arch was also found in endothelin-1 deficient mice (12) . This is also observed in mice in which Bmp4 is conditionally inactivated within the Tbx1 expression domain (22) , and it is of note that in these mice the initial patterning is normal, a feature that is very similar to our mutant mice. Bmp4 knockout study showed Bmp4 requirement for recruitment/differentiation of smooth muscle cells surrounding the pharyngeal arch arteries (22) . Section in situ hybridization method for Bmp4 mRNA showed reduced expression in Nkx2. Foxc2 fl/fl mutant embryos compared to control (data not shown). This data suggest that Foxc2 has association with Bmp4 signalling in the mesenchyme of pharyngeal arch arteries. Our histologic analysis showed VSD only in Nkx2. Foxc2 fl/fl mutant embryos. Inactivation of Foxc2 may cause the loss of Bmp4 function for growth of the contruncal mesenchyme necessary for septum formation (22) . Loss of function of several other genes including pitx2c, Crkl, Tgfβ causes interrupted aortic arch in addition to other cardiovascular defects (5, 15, 20) . We also found IAA-B when Foxc2 was inactivated using secondary heart field specific Isl1-Cre and Tbx1-Cre mice (unpublished data). Recent studies showed that Nkx2.5 is expressed in the first heart field, second heart field pharyngeal mesoderm and its adjacent endodermal cells (34) . Interestingly, our Nkx2.5-Cre; Foxc2 fl/fl mutant embryos showed IAA-B; these data support the fact that Nkx2.5 is expressed in some part of the secondary heart field in addition to the primary heart field. In contrast to Nkx2. 5 fl/fl mutant embryos, which was considered to result in embryonic lethality. These results suggest that Foxc2 is also involved in the embryonic lymphatic vessels development that are associated with LD syndrome. Previous studies showed that half of the Foxc2 null embryos died during gestation and those remaining died just after birth, whereas Foxc2 conditional embryos only died just after birth (Table 1) .
understood. Previously, the functions of Foxc2 for normal development of the aortic arch have been analysed. Simple knockout of Foxc2 in mice showed aortic arch remodelling defect, skeletal malformation and other cardiovascular defects. Foxc2 is required for extensive remodelling of the dorsal aorta and arch arteries, particularly the fourth arch artery, to form the aortic arch (6) . In this study, we examined the expression of Foxc2 in the pharyngeal arch arteries of E10.5 control and mutant mouse embryos by immunostaining. Foxc2 was strongly expressed in the surrounding mesenchymal cells and endothelium of the third, fourth and sixth pharyngeal arch arteries of control embryos (Fig. 3 A-C) . Information regarding Foxc2 expression in cardiac progenitors during critical stages of aortic arch remodelling has been poorly described and it is not clear in which cell populations Foxc2 plays a role in aortic arch remodelling. We therefore considered the Cre-driver strategy to be an effective way to cell type-specific deletion of Foxc2 in aortic arch remodelling. We ablated Foxc2 using mesenchyme-and endothelial-specific Cre The neonatal embryonic death may be due to the inability to inhale air into the lungs in addition to interruption of the aortic arch. Our results showed normal aortic arch patterning when intracardiac ink injection was performed into the heart of E12.5 control and mutant embryos. At E13.5, the most common defect, seen in all Nkx2. Foxc2 fl/fl mutant embryos, was absence of fourth arch artery derivatives, which led to the interruption of the aortic arch (Fig. 6) . Cardiac neural crest cells ablation in chick embryos causes cardiovascular phenotypes including aortic arch remodelling defect. These data demonstrated that cardiac neural crest-derived cells are important for aortic arch remodelling (9, 10) . It is clear from this and other studies that Foxc2 is not involved in the initial formation or patterning of pharyngeal arch arteries but affects their remodelling process. The morphology and final rearrangement of these great vessels require reciprocal signalling between neural crest cells-derived mesenchyme surrounding the arch arteries (13) and endothelial cells (33) . Our results suggest that future studies are required to determine whether Foxc2 interacts with some secreted molecules or other transcription factors in the mesenchyme derived from cardiac neural crest cells surrounding pharyngeal arch arteries during the remodelling process.
In conclusion, our study clearly demonstrated that expression of Foxc2 in the mesenchyme of pharyngeal arch arteries is important for aortic arch remodelling. In addition to this, our conditional Foxc2 mouse can be used as a powerful tool to reveal the molecular mechanisms and genetic determinant that are involved in aortic arch remodelling.
